Dr. Jerome M. Magolan

Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone is rated as an Elite provider by MediFind in the treatment of Doyne Honeycomb Retinal Dystrophy. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), and Usher Syndrome Type 2A. Dr. Iannaccone is currently accepting new patients.

John Denny is an Ophthalmologist in Cary, North Carolina. Dr. Denny is rated as a Distinguished provider by MediFind in the treatment of Doyne Honeycomb Retinal Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Adult-Onset Vitelliform Macular Dystrophy (AVMD). Dr. Denny is currently accepting new patients.

I am an ophthalmologist who specializes in the diagnosis and management of medical conditions affecting the retina, including macular degeneration (AMD), diabetic retinopathy, retinal vein occlusion, macular edema, and other macular diseases. I believe that no two patients are exactly alike. For each of my patients, I carefully consider exam findings, imaging, and patient needs and preferences to create a customized treatment plan. In addition to patient care, I study the biology, diagnosis and treatment of macular edema, and I am involved in basic laboratory science, ocular imaging analysis and clinical trials of new medications. I think that my time in clinic drives my research and that the insights gained from my research keep me at the cutting edge of diagnosis and treatment strategies for my patients. Outside of work I spend as much time as possible outdoors with my wife and daughter. In whatever time is left I can be found exploring western North Carolina on my mountain bike. Dr. Allingham is rated as a Distinguished provider by MediFind in the treatment of Doyne Honeycomb Retinal Dystrophy. His top areas of expertise are Geographic Atrophy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Vein Occlusion.